Therapeutic plasma exchange for neonatal hepatic failure

Transfus Apher Sci. 2023 Dec;62(6):103810. doi: 10.1016/j.transci.2023.103810. Epub 2023 Sep 9.

Abstract

We report a case of therapeutic plasma exchange in a neonate with fulminant liver failure. A six-day old, 2800-gram baby was referred to our medical center for evaluation and treatment of fulminant hepatic failure. The working diagnosis at admission was gestational alloimmune liver disease, and therapeutic plasma exchange was proposed. A double volume plasma exchange was successfully performed, using the Spectra Optia apheresis system, primed with packed red blood cells. Access was obtained via a radial artery catheter and a peripheral intravenous line. On hospital D-14 a diagnosis of E3 deficiency was confirmed, and disease-specific therapy was started. Automated TPE using peripheral arterial and venous catheters may be safely performed in neonates, and should be considered in the treatment of a variety of disorders including neonatal fulminant hepatic failure.

Keywords: E3 deficiency; Gestational alloimmune liver disease; Liver failure; Plasma exchange; Spectra optia.

Publication types

  • Case Reports

MeSH terms

  • Catheters
  • Humans
  • Infant, Newborn
  • Liver Failure, Acute* / therapy
  • Plasma Exchange*
  • Plasmapheresis